# SABER Study for Selected Early Stage Breast Cancer

> **NCT04360330** · NA · RECRUITING · sponsor: **University of Miami** · enrollment: 18 (estimated)

## Conditions studied

- Breast Cancer
- Early-stage Breast Cancer

## Interventions

- **RADIATION:** Stereotactic Ablative Breast Radiotherapy

## Key facts

- **NCT ID:** NCT04360330
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-08-05
- **Primary completion:** 2026-05
- **Final completion:** 2028-05
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04360330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04360330, "SABER Study for Selected Early Stage Breast Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04360330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*